The Patient Centered Outcomes Research Institute (PCORI) recently issued a second call for large pragmatic study proposals and is offering up to $90 million to support up to nine large comparative clinical effectiveness research studies. This type of studies tend to better reflect actual care […]
And The Winner Of The Informatica Innovation Award Is…… ICON!
Carefully chosen from more than 5,000 Informatica customers, ICON plc was the only CRO to receive the prestigious Informatica Innovation Award for Improved Decisions. Learn more here. (Source: ICON,5/15/14). […]
Evolution Of Clinical Research – Was The First Trial Recorded In The Bible?
May 20th is the anniversary of the 1st clinical trial ever conducted by James Lind, the famous Scurvy Citrus fruit trial. Take a trip down memory lane as this article covers the long and fascinating journey of the evolution of clinical research; from legumes in biblical times to scurry, streptomycin […]
What’s To Blame For The Failing Of Evidence-Based Medicine?
This paper suggests that EBM's potential for improving patients' health care has been thwarted by bias in the choice of hypotheses tested, manipulation of study design and selective publication. Read more here. (Source: PubMed.gov, 5/12/14). […]
Free White Paper! Learn more about Clinical Trials in Russia
inVentiv Late Stage Clinical Trials
inVentiv Health Clinical Late Stage Clinical Trials 3.24.2014
More information here. […]
Clinical Trials – How To Keep The Patient From Breaking Up With You
A successful clinical trial must maintain high levels of patient recruitment, adherence and retention, but this proves to be a significant challenge for researchers. Enter Behavioral Economics (BE), based on the idea that our behavior is mainly unconscious, irrational and socially driven. […]
Upcoming Webinar On Clinical Trial Design And Development Strategy
Context Matters CEO, Yin Ho, will be on a panel for the upcoming free webinar, Transforming Clinical Development Strategy and Performance With Real-World Data. The webinar is sponsored by Oracle Health Sciences and Pharmaceutical Executive. More information here. (Source: Context Matters, […]
How Is Pharma Being Compared To Tobacco Companies?
How much honesty can we expect from industry-backed research? According to this author- not very much. Which is why he has called for medical journals to ban the publication of research funded by pharma companies. Read more here. (Source: PMLiVE, 1/17/14). […]
Podcast On Clinical Trial Transparency
In this podcast, Pharma IQ discusses the issue of clinical trial transparency with Dr. Goldacre, with a focus on how it will affect industry and why pharma companies have taken differing strategies in response to the campaign. Listen to podcast here. (Source: Pharma iQ, 1/21/14). […]
FDA Reaching Milestones With COA Developers
Evidera recently announced the release of FDA Draft Guidance on the use of the Qualification of Exacerbations of Chronic Pulmonary Disease Tool (EXACT), to measure symptoms of COPD Exacerbations. Read more. (Source: PR Newswire, 1/14/14). […]
Pragmatic Clinical Trials in 2014
With the Patient-Centered Outcomes Research Institute (PCORI) announcing plans to fund PCTs in 2014, stakeholders are going to be hearing a lot more about this type of research. Learn more about PCTs here. (Source: NPC, Dec 2013). […]
Will Clinical Trial Recruitment Make It In The Digital World?
There are an increasing number of clinical trial search services popping up, but efforts to harness digital channels for patient recruitment are still at an experimental stage. While more and more patients are going online for health reasons, the potential is obvious, but what is the best way to […]
How To Run Successful Trials in Emerging Regions
The clinical development world is shrinking and running trials in emerging regions is becoming increasingly desirable and acceptable. This webinar, jointly presented by Pharm-Olam and ERT, will address the challenges most commonly faced by sponsor companies: managing patients, investigative sites, […]
The Moral Issues Behind Clinical Trials
As the cost of clinical trials continues to increase, pharmaceutical companies have chosen only those drugs in which they feel very confident on bringing a return. Often, leaving potentially life saving drugs on the self. How do we get more of these drugs to market at a reduced cost and risk to […]
